Medtronic Expands Stealth AXiS To Cranial, ENT
Medtronic said on March 28, 2026 the U.S. FDA cleared its Stealth AXiS surgical system for cranial and ear, nose and throat procedures, expanding the platform beyond a February spine indication. The system combines navigation, imaging, robotics and uses AI to auto-generate brain maps; the company also cut its fiscal 2026 profit forecast to $5.50–$5.54 after a roughly $157 million one-time charge.
Scoring Rationale
Regulatory milestone with direct clinical applicability; limited novelty since it extends existing platform rather than introducing new capabilities.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all Health & Insurance problemsStep-by-step roadmaps from zero to job-ready — curated courses, salary data, and the exact learning order that gets you hired.
Sources
- Read OriginalMedtronic gets US FDA nod to use surgical system in cranial, ENT surgerieshealth.economictimes.indiatimes.com
